TORONTO, ONTARIO--(July 7, 2017) -

 

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

 

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that it has completed its initial public offering (the "Offering") of common shares ("Common Shares"), including a treasury offering (the "Treasury Offering") and a secondary offering (the "Secondary Offering") by certain shareholders (the "Selling Shareholders"), including an entity which is controlled by certain funds to which investment advisory services are provided by CCMP Capital Advisors, LP ("CCMP"), of an aggregate of 19,050,000 Common Shares at a price of $15.75 per share (the "Offering Price") for total gross proceeds of $300,037,500, with Jamieson Wellness and the Selling Shareholders receiving gross proceeds of $244,987,391 and $55,050,109, respectively. 

Multi-Country Agreement Widens Distribution in Key Asian Markets for ICE COLD-PCR Liquid Biopsy Technology that Enables Precision Medicine Provides Clearbridge Health's Network of Physicians and Patients with Access to Precipio's Platform for Optimizing Personalized Diagnosis and Treatment

 

NEW HAVEN, CT / July 5, 2017 / Precipio Inc. (NASDAQ: PRPO) today announced a multi-country agreement with Clearbridge Health, Pte. (CBH), to provide its ICE COLD-PCR (ICP) technology in CBH's network of laboratories, serving patients in more than a dozen countries throughout Asia, including China, India, Taiwan, South Korea, Singapore, Malaysia, Indonesia, and Australia. Those laboratories will incorporate the Company's ICP technology into their operations over the coming months, and are expected to begin offering liquid biopsy diagnostic services to local physicians soon thereafter. CBH will provide Precipio's diagnostic services, as well as access to its world-class academic experts, to physicians and patients throughout the Clearbridge Health network. The agreement is expected to significantly increase Precipio's footprint in the Asian market.

SOMERSET, NJ--(Jun 14, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading industry consolidator and provider of proprietary, cloud-based healthcare IT solutions, today announced the initial launch of MTBC WebSoft™, the newest addition to its leading cloud-based healthcare IT platform which will further support scalability, acquisition integration, and margin expansion.

 

"MTBC WebSoft leverages state of the art technology -- ASP.NET MVC framework and AngularJS 2.0 -- to optimize performance, empower us to scale with increasing efficiency, and enable us to further streamline the integration of newly acquired customer bases," said Hadi Chaudhry, Vice President of Global Operations. He continued, "As a top consolidator in our space that has grown year-over-year revenues by more than 60% during the most recent two quarters, this is precisely the type of tool we need to ensure that we remain ahead of the industry for many years to come as we continue our expansion into new markets."

2017-06-13 07:00 ET - News Release

 

WALTHAM, Mass. --  NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,675,801.

 

The patent covers novel mechanisms to help Quell® users safely obtain pain relief therapy over prolonged time periods. More specifically, the patent includes claims for technology to monitor the amount of time that Quell is worn both continually and in the aggregate, and to provide notifications to the user to maximize safety.